Product image of Marcaine Spinaal (Bupivacaine Hydrochloride, Anhydrous) supplied by GNH India

Marcaine Spinaal

Active Ingredient:
Bupivacaine Hydrochloride, Anhydrous
Origin:
EU

Marcaine Spinaal (Bupivacaine Hydrochloride, Anhydrous)

Bupivacaine hydrochloride, the active ingredient in Marcaine Spinaal, is a local anesthetic presented as a sterile solution for intrathecal and infiltration use. It provides profound sensory blockade for surgical procedures, regional nerve blocks and spinal anesthesia in adult patients.

GNH India supplies Marcaine Spinaal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Aspen Pharma Trading Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Marcaine Spinaal is a local anesthetic used in various anesthesia techniques to achieve reversible loss of sensation.

  • Surgical anesthesia: enables complete analgesia for operative procedures requiring general or regional techniques.
  • Regional nerve block: provides targeted numbness for limb or trunk surgeries.
  • Epidural and spinal anesthesia: produces reliable sensory block for obstetric, urologic and orthopedic interventions.

How It Works

  • Bupivacaine hydrochloride blocks voltage‑gated sodium channels on neuronal membranes, preventing the initiation and propagation of action potentials. By stabilising the neuronal membrane, it inhibits nerve impulse transmission, resulting in reversible loss of sensation in the administered area.

Side Effects

Marcaine Spinaal may be associated with a range of adverse reactions following administration.

Common Side Effects

  • Hypotension: transient drop in blood pressure.
  • Bradycardia: slowed heart rate.
  • Nausea: mild to moderate upset stomach.
  • Dizziness: feeling of light‑headedness.
  • Pruritus: localized itching at injection site.
  • Headache: mild post‑procedural headache.

Serious or Rare Side Effects

  • Cardiac arrhythmia: abnormal heart rhythm.
  • Central nervous system toxicity: seizures or altered mental status.
  • Respiratory depression: reduced breathing effort.
  • Allergic reaction: rash, swelling or anaphylaxis.
  • Persistent neurologic deficit: prolonged numbness or weakness.
  • Spinal hematoma: bleeding in the spinal canal.

Precautions & Warnings

When using Marcaine Spinaal, clinicians should observe specific safety measures.

  • Patient assessment: evaluate cardiovascular and neurologic status before administration.
  • Dose limitation: avoid exceeding recommended maximum dose for the specific route.
  • Monitoring: continuously observe vital signs and level of block during the procedure.
  • Contraindications: do not use in patients with known hypersensitivity to amide‑type local anesthetics.
  • Drug interactions: review concomitant medications that may affect cardiac conduction.
  • Storage: Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Marcaine Spinaal can interact with other agents that influence cardiac or neurologic function.

Major Interactions (Avoid)

  • Class I anti‑arrhythmics (e.g., quinidine, procainamide): may potentiate cardiotoxicity.
  • Beta‑blockers: increase risk of severe bradycardia.
  • Central nervous system depressants (e.g., opioids, benzodiazepines): may enhance respiratory depression.

Moderate Interactions (Monitor Closely)

  • Calcium channel blockers: may affect cardiac conduction.
  • MAO inhibitors: potential for enhanced local anesthetic toxicity.
  • Diuretics: may alter plasma protein binding, affecting drug levels.

Frequently Asked Questions

Marcaine Spinaal is a sterile solution of bupivacaine hydrochloride used to provide local anesthesia for surgical procedures, regional nerve blocks, and epidural or spinal anesthesia. It creates a reversible loss of sensation in the targeted area, facilitating pain‑free surgery and diagnostic interventions.

Bupivacaine blocks voltage‑gated sodium channels on nerve membranes, preventing the initiation and propagation of action potentials. This inhibition stops nerve signal transmission, resulting in temporary loss of sensation and pain perception in the region where the drug is administered.

The dose of Marcaine Spinaal is determined by the prescribing clinician based on the specific procedure, patient characteristics, and route of administration. Healthcare professionals calculate the appropriate amount to achieve effective anesthesia while staying within safety limits.

Safety data for bupivacaine in pregnancy and lactation are limited. Use during pregnancy or while breastfeeding should only be considered if the potential benefit justifies any potential risk to the fetus or infant, and it must be decided by a qualified healthcare provider.

To order Marcaine Spinaal, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Bupivacaine, the active ingredient in Marcaine Spinaal, has a longer duration of action compared with agents such as lidocaine or mepivacaine. This makes it suitable for procedures requiring prolonged anesthesia, though it may carry a higher risk of cardiotoxicity at excessive doses.

Marcaine Spinaal should be stored at 2‑8 °C in a refrigerator, protected from light. Do not freeze or shake the vial. Maintaining the cold‑chain ensures the stability and potency of the bupivacaine solution.

Marcaine Spinaal is administered by a trained healthcare professional via infiltration, intrathecal injection, or epidural placement. The exact technique depends on the intended block and the anatomical site, and it is performed under aseptic conditions.

Serious risks include cardiac arrhythmias, central nervous system toxicity such as seizures, respiratory depression, and rare events like spinal hematoma. Prompt recognition and management of these complications are essential during and after administration.

Patients with known hypersensitivity to bupivacaine or other amide‑type local anesthetics, those with severe cardiac conduction disorders, or individuals with significant neurologic disease should avoid Marcaine Spinaal unless a risk‑benefit assessment justifies its use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Bupivacaine Hydrochloride, Anhydrous

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT